Trials / Recruiting
RecruitingNCT06140147
Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,850 (estimated)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this trial is to assess the beneficial and harmful effects of a restrictive strategy for administration of non-resuscitation fluids in adult patients with septic shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Protocolised reduction of non-resuscitation fluids | Maintenance fluid: discontinued if cumulative fluid balance is positive and patient is not dehydrated Intravenous fluid and enteral water: as needed to correct electrolyte disturbances Enteral nutrition (at least 2 kcal/ml): per local practice Glucose (conc. ≥20%, dose ≤1g/kg/day): may be used as nutrition if enteral feeding not tolerated starting 72h after inclusion. May be started earlier in patients with insulin-dependent diabetes or risk of hypoglycemia per local practice Parenteral nutrition: per local practice Intravenous medications: concentrated according to a predefined protocol Patients with neutral or negative cumulative fluid balance receive maintenance and other fluids so the total dose of fluids covers the daily need of water (about 1ml/kg/h) |
| OTHER | Usual care | Participants receive non-resuscitation fluids according to local routines, with the following stipulations: Maintenance fluids (crystalloids and/or glucose and/or enteral water): given at a dose of 1 ml/kg/h unless local protocol states otherwise Glucose: used at maximal concentration of 10% unless local protocol states otherwise. Medications: concentrated per local protocol |
Timeline
- Start date
- 2023-11-27
- Primary completion
- 2027-12-31
- Completion
- 2028-07-01
- First posted
- 2023-11-18
- Last updated
- 2026-04-01
Locations
22 sites across 3 countries: Finland, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT06140147. Inclusion in this directory is not an endorsement.